Lipella Pharmaceuticals Inc. Board of Directors

Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.

Dr. Jonathan Kaufman M.B.A., Ph.D.

Dr. Jonathan Kaufman M.B.A., Ph.D.

Co-Founder, Chairman, CEO, President, Secretary & Treasurer

Dr. Michael B. Chancellor M.D.

Dr. Michael B. Chancellor M.D.

Co-Founder, Chief Medical Officer & Director

Mr. Douglas Johnston CPA

Mr. Douglas Johnston CPA

Chief Financial Officer

Ms. Michele Gruber

Ms. Michele Gruber

Director of Operations

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.